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Background: The primary objective of the present investigation is to evaluate the antidiabetic, antihyperlidemic
and antioxidant activity of the methanolic extract of the Paederia foetida Linn. (PF) leaf extract in the streptozotocin
induced diabetic rats.
Methods: Single intraperitoneal injection (IP) of streptozotocin (60 mg/kg body weight) was used for induction of
diabetes is swiss albino (wistar strain) rats. The induction of diabetes was confirmed after 3 days as noticing the
increase in blood sugar level of tested rats. PF at a once a daily dose of 100 mg/kg, 250 mg/kg, 500 mg/kg, p.o.
along with glibenclamide 10 mg/kg, p.o. was also given for 28 days. On the 28th day rats from all the groups fasted
overnight fasted and the blood was collected from the puncturing the retro orbit of the eye under mild anesthetic
condition. There collected blood sample was used to determine the antihyperlipidemic, hypoglycemic and
antioxidant parameters.
Results: The oral acute toxicity studies did not show any toxic effect till the dose at 2000 mg/kg. While oral
glucose tolerance test showed better glucose tolerance in tested rats. The statistical data indicated that the
different dose of the PF significantly increased the body weight, hexokinase, plasma insulin, high density lipoprotein
cholesterol, superoxide dismutase, catalase and glutathione peroxides. It also decreases the level of fasting blood
glucose, total cholesterol, triglycerides, low density lipoprotein cholesterol, very low density lipoprotein cholesterol,
malonaldehyde, glucose-6-phosphate, fructose-1-6-biphosphate and glycated hemoglobin in STZ induced diabetic
rats. The histopathology of STZ induce diabetic rats, as expected the test dose of PF extract considerably modulates
the pathological condition of various vital organ viz. heart, kidney, liver, pancreas as shown in the histopathology
examinations.
Conclusions: Our investigation has clearly indicated that the leaf extract of Paederia foetida Linn. showed
remarkable antihyperglycemic activity due to its possible systematic effect involving in the pancreatic and extra
pancreatic mechanism. Forever, the antihyperlipidemic activity was exerted possible by lowering the higher level of
lipid profile and decreasing the intercalated disc space in the heart. The antioxidant activity of extract was due to
inhibition of lipid peroxidation and increasing the SOD, GPx and CAT. It was corroborate that the extract shown the
Paederia foetida Linn leaves potential to be act as antidiabetic, antihyperlipidemic and antioxidant properties.
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Diabetes mellitus (DM) is a condition in which the
amount of glucose increases in the blood, because organs
viz. adipose tissues and liver does not properly utilize the
glucose. DM occurs due to hereditary and environmental
causes, resulting in abnormally high blood sugar level
[1,2]. The role of the insulin in the body it release after a
meal from the pancreas and stimulate the fat cells and
muscle to remove the glucose from the blood and stimu-
late the liver to metabolize glucose, causing the blood
sugar level to decrease to normal level. According to the
WHO (World Health Organization) an estimated 300 mil-
lion during World, 57.2 million adults in India affected in
the year 2025 [3,4]. DM is the most common manifest-
ation of metabolic disorder occurs in human due to the
high consumption of carbohydrates and lipids [5].
Hyperglycaemia an associate with hyperlipidemia in the
late phase of life is also prone to diabetes [6]. It is the
complex metabolic endocrine disorder which resulting
from disequilibrium of dynamic expression, causing the
macro (heart attack, stroke and peripheral vascular dis-
ease) and micro (retinopathy, neuropathy and nephrop-
athy) vascular complications [7,8]. Further, increase in
the blood glucose level in diabetic patient causes alter-
ation in utilization of glucose in the vital organs viz. adi-
pose tissues and liver of the body. Increased in blood
glucose level continuously generating reactive oxygen
species (ROS) and superoxide anions, which further ag-
gravate the diabetic complication by damaging the pro-
tein, deoxyribosenucleic acid and carbohydrate, which
leading to increasing the oxidative stress [9-12]. The
concentration of free radical production could be favor-
ably reduced through appropriate dietary intake and
drug therapy and thus less chance of diabetes and dia-
betic associated CVS disorder. Since there is no current
treatment available for hypoglycemic, hypolipidemic
and antioxidant drug together therefore, researchers are
continuously working on discovery of effective drug to
exert the action on hyperglycemia, hyperlipidemia and
antioxidant effect with minimal or no signs of side or
toxic effects.
Medicinal plants play as important role in the discovery
of new counteractive agents and received much more at-
tention as a source of biologically active substance includ-
ing antioxidant, antihyperglycemic and antihyperlipidemic
agents [13]. Since few decades, plants were used to treat
diabetes and its complications. 400 plants and there 700
recipes in the formulation were used for the treatment of
diabetes [14]. Consequently, modern medical science ex-
plores this fruitful field and thus discovered a first clinically
used drug of its own kind from to treat diabetes i.e. metfor-
min (Galega officinalis). By above investigation and the role
of plant in generation of antidiabetic agents [15]. Present
investigation carried out to evaluate the antidiabetic,antihyperlipidemic and antioxidant stress activity of Pae-
deria foetida Linn.
Paederia foetida Linn. Belonging to family Rubiaceae,
commonly known as Ghandhali in across the India and
usually found upto an altitude 1800 m in Himalaya re-
gion. in folklore system of medicine it was indicated for
the treatment of gout, diarrhea, piles, dysentery, calculi,
stomachic, emetic, ulcers and different type of inflamma-
tions [16-19]. It has also been reported for antinocietive
[20], antiviral [21], antidiarrhoeal [22], anti tussive [23],
anti-inflammatory [24] and anti cancer activity [25]. It was
reported that majority of chemical constituents were
found in leaves of Paederia foetida Linn., these chemical
constituents comprise of iridoid glycoside, sitosterol, alka-
loids, carbohydrates, β-sitosterol, ascorbic acid, flavonoids,
amino acids, stigmosterol, D/L galacturonic acid and
volatile oil Paederia foetida Linn. [26-28]. The aim of the
present study was to evaluate the antidiabetic, antihyperli-
pidemic and antioxidant activity of the methanolic extract




Fresh leaves of Paederia foetida Linn. was collected from
Herbal garden, Department of Life Sciences, Dibrugarh
University, Dibrugarh, Assam, India and authenticated
by the Botanical Survey of India, Shillong, India. A vou-
cher specimen (Ref. No.DU/PSc/HRB-2/08) was depos-
ited for future reference.
Preparation of crude extracts
The collected leaves of PF were gently washed with tap
water to remove the extraporeneous matter. After rins-
ing, the leaves were dried in shade at room temperature.
The leaves were grounded and approximately 2 kg leaves
were extracted with methanol in a Soxhlet apparatus for
5 days. The filtrate obtained after filtration of above men-
tion extract was concentrated under reduced pressure at
4°C using rotatory evaporator until the extra solvent com-
pletely disappear resulting the crude semisolid residue
(percentage yield, 30%). The resulting product was then
stored at 4°C until further use. To carry out animal studies
of this product, it was dissolved in 2% solution of CMC
(Carboxyl methyl cellulose) in distilled water [28-30].
Extract standardization by HPTLC technique
Preparation of standard and sample solution
A stock solution of quercetin and ascorbic acid was pre-
pared by dissolving 10 mg of standard quercetin in 10 mL
of methanol (1000 μg/mL) and used as standard. The sam-
ple solution was prepared by extracting 2.0 g of dried pow-
dered crude drug with 50 mL of methanol. The methanolic
extract was filtered through the Whatman filter paper and
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obtained was re-dissolved in 1.0 mL of methanol and used
for chromatography.
HPTLC instrumentation and procedure
The sample was carefully spotted in the precoated silica
gel aluminum plate 60 F-254 (10 cm× 10 cm with 0.2 mm
thickness, E. Merck, Germany) using a Camag Linomat V
(Switzerland) in the form of the bands of width 4.0 mm
with a Camag microliter syringe with 150 nL/s constant
application rate. A constant application rate 150 nL/s was
employed. The slit dimension was kept at 4.0 mm×
0.45 mm and 20 mm/s scanning speed was employed. The
mobile phase was composed of hexane:ethyl acetate: for-
mic acid (5:4:1, v/v/v). The development of the HPTLC
plate was carried out in ascending manner in twin trough
glass chamber. The saturation time for the mobile phase
20 min in the saturation chamber and chromatogram was
developed up tot the length 80 mm of the HPTLC plate
and dried in the room temperature. The scanning was
done in absorbance mode up to 570 nm.
Animals
Healthy albino rats (Wistar strain) weight about 150-200 g
were used. The entire animals used in the studies were
kept in individual polyethylene cages and maintained
standard condition (12 h dark and 12 h light circle; 25 ±
5°C; 40-60% humidity). The animals treated with standard
fed ad libitum with normal laboratory chow standard pel-
let diet, purchased from the Hindustan Liver Limited,
Mumbai, India. The animals were allowed to acclimate for
7 days before starting the experiments. All the studies
were conducted in accordance with the Animal Ethical
Committee as constituted by Siddhartha Institute of Phar-
macy and the experimental protocol was approved by the
Institutional Animal Ethical Committee of Siddhartha In-
stitute of Pharmacy (1435/PO/a/11/CPCSEA).
Oral acute toxicity studies
For determination the oral acute toxicity studies the ani-
mals were starved overnight (16 h) and divided into six
group (n = 6). Entire groups of tested animals received
graded doses of PF extract dose raising level 100-2000 mg/
kg body weight (i.e. 100, 250, 500, 1000, 2000 mg/kg body
weight) and the animal was observed continuously for
2 h for on the basic of the following parameter after
dosing [31,32]. The control group rats received vehicle
only.
1: Behavioral changes viz., restlessness, irritability,
alertness and fearfulness
2: Neurological changes viz., spontaneous activity,
touch response, reactivity, pain response and gait
3: Autonomic changes viz., urination and defecationThese treatments observed for any changes and contra-
indication, death occurs during 24 h and 72 h.
Effect of PF extract on glucose-hyperglycaemias animal
model (glucose-loaded model, oral glucose tolerance test,
OGTT)
This test was performed on overnight (16 h) famished nor-
mal albino wistar rat. The rats were randomly divided into
seven groups and each group having 6 rats, while, [33].
Group I: rats was treated with vehicle only,
Group II: rats was treated with vehicle only + PF extract
500 mg/kg body weight,
Group III: rats was treated with vehicle only + Glucose
2 g/kg body weight,
Group IV: rats was treated with PF extract 100 mg/kg
body weight,
Group V: rats was treated with PF extract 250 mg/kg
body weight,
Group VI: rats was treated with PF extract 500 mg/kg
body weight, and last group
Group VII: rats treated with Glibenclamide 10 mg/kg
body weight.
After giving the respective option for the groups of the
rats at mention above a single dose of 2 mg/kg of glu-
cose was given to all the group after 30 min of initial
feeding except group I and group II. Blood was drawn
from the tail vein at regular intervals of time 0, 30, 60,
90, 120 and 150 min, blood glucose level were analyzed
by the GOD-POD kit (Span diagnostic) following the
given instruction by the manufacturer.
Induction of diabetes
Swiss albino (wistar strain) rat was used for the induc-
tion of diabetes. Before the experimentation performs all
animals were starving overnight (16 h). Diabetes was in-
duced by single intraperitoneal injection (i.p.) of streptozo-
tocin (60 mg/kg body weight) prepared by streptozotocin
dissolving in 0.1 M citrate buffer (pH = 4. 5). All groups
animal received the dose of STZ (60 mg/kg body weight)
except normal control and normal control + PF (500 mg/
kg) group rats. After 5 days all the groups’ animal blood
samples collected from the puncturing the retro-orbits of
the rat eyes and determine the blood glucose level using
the GOD-POD method following the given instruction
by the manufacture. The diabetes was confirmed by the
elevating the blood glucose levels (220 mg/dl) were utilized
for the study [34].
Experiment with design
After successfully developing the diabetes animals
were divided into seven groups and each group contain
six rats.
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Group II: normal control rats administered PF extract
500 mg/kg body weight
Group III: diabetic control rats administered drinking
water alone
Group IV: tested rats administered PF extract 100 mg/kg
body weight
Group V: tested rats administered PF extract 250 mg/kg
body weight
Group VI: tested rats administered PF extract 500 mg/kg
body weight
Group VII: tested rats administered glibenclamide
10 mg/kg body weight
All group rats received different doses of PF extract
and glibenclamide using intragastric tube once daily for
28 days, continuously [35]. The blood samples of each
animal were collected from the puncturing retro-orbital
plexus and preserve anticoagulating agents; blood sample
was centrifuged at 4000 RPM at 250°C for 15 min and an-
alyzed for various biochemical parameters. The plasma
insulin level was assayed by the radio-immunoassay
method. All group rats serum glucose analysis was done
by glucose oxidase-peroxidase (GOD-POD) method using
Glucose estimation kit (Span Diagnostic, India). Other
serum estimation done by spectrophotometrically using
standard kit and following the given instruction. SerumFigure 1 High performance thin liquid chromatography profiles of Patriglyceride, total cholesterol, HDL (High Density Lipo-
protein) cholesterol was analyzed by standard kits
(Span Diagnostic, India) and other LDL (Low Density
Lipoprotein) cholesterol [36], VLDL (Very Low Density
Lipoprotein) were estimated with the help of the fol-
lowing formulas.
LDL ¼ TC=1:19þ TG=1:9‐HDL=1:1‐38 mg=dLð Þ
VLDL ¼ triglycerides mg=dLð Þ=5
Estimation of antioxidant enzymes
For the estimation of the antioxidant enzymes, all groups
rats’ liver successfully removed and homogenate. Liver
homogenate prepared with ice chilled 10% potassium
chloride solution, was used to measure the levels and activ-
ities of superoxide dismutase (SOD) [37], catalase (CAT)
[38], glutathione peroxidase (GPx) and Malondialdehyde
(MDA) by the method of [39,40].
Histopathology
At the end of the study 28 days all the groups animal
were sacrificed under using mild anesthesia and isolated
the different organ (heart, liver, pancreas and liver) of the
animal for histopathology. All the animals were tested for
absolute and relative organ weight and gross pathological
lesions. The isolated organ (heart, liver, pancreas and liver)ederia foetida extract.
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by passing through a graded series of alcohol, and embed-
ded in paraffin blocks and 5 mm sections were developed
using a semi-automated rotatory microtome. Hematoxylin
and eosin were used for staining [40].
Statistical analysis of experimental data
Values were presented as means ± standard error of the
mean (S.E.M.). Statistical differences between the treat-
ments and the controls were tested by one-way analysis
of variance (ANOVA) followed by the Dennett’s test
using the “Graph Pad Prism” statistic computer pro-
gram. A difference in the mean values of p < 0.001 was
considered to be statistically significant. Inhibition per-
centages were computed as follows:





The HPTLC finger print result for methanolic extract of
PF showed the three phytoconstituents and correspond-
ing the Rf values start from the 0.3 to 0.93 (Figure 1).Figure 2 High performance thin liquid chromatography profiles of staThe HPTLC analysis of PF extract showed the com-
pound with Rf 0.77 as ascorbic acid as compared to the
standard HPTLC graph of ascorbic acid (Figure 2).
Acute oral toxicity study in rats
Oral acute toxicity study, different doses of PF treated
groups animals did not show any change in the behav-
ioural, anatomical and neurological pattern. In complete
study all the groups’ animals did not indicate any changes
in the body weight and food consumption when compared
to the vehicle treated groups. Therefore, it was concluded
that the dose up to 2000 mg/kg of the PF extract was safe
for the use.
Effect of PF on oral glucose tolerance test
The consequence of the acute effect of graded doses of
PF extract on blood sugar level of normal healthy rats
and glucose loaded were presented in the Figure 3. Oral
administration of different doses of PF extract and gliben-
clamide significantly decline (P < 0.001) the rise in blood
glucose levels, after glucose administration. After loading
the glucose, it was observed that glucose control group
rats showed the higher AUCglucose values (Figure 3). Oral
administration of the different doses of the PF (100, 250ndard Ascorbic acid.
Figure 3 Oral glucose tolerance and AUC of PF leaves extracts in normal rats. Values are given as mean ± S.E.M. of six rats in each group.
*p ≤ 0.05, **p ≤ 0.005, ***p ≤ 0.001 compared with normal control values.
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AUCglucose values as compared to the glucose control
group rats (Table 1).
Effect of PF on blood glucose level
The antidiabetic effect of repeated oral administration of
PF leaves extract on STZ (streptozotocin) induced dia-
betic rats was presented in Table 2. Three different doses
of PF leaves extract (100, 250 and 500 mg/kg) to STZ in-
duced diabetic rats caused significantly (P < 0.001) de-
cline the blood glucose level which was showing dose
and duration of treatment. Maximum reduction of blood
glucose was observed at day 28 (55.74%, 61.76% andTable 1 Pharmacokinetic parameters of Paederia foetida
Linn. extract in Oral glucose tolerance test







1 Glucose control 119.4 30 16239
2 Glucose + PF I (100 mg/kg) 114.2 30 14847
3 Glucose + PF II (250 mg/kg) 110.2 30 13929
4 Glucose + PF III (500 mg/kg) 105.2 30 12645
5 Glucose + Glibenclamide
(10 mg/kg)
107 30 13020
Each parameter represents the mean of Six animals. Area under curve (AUC)
values. tmax, time at maximum observed concentration; Cmax,
maximum concentration.69.12% respectively). PF dose 500 mg/kg shown the max-
imum reduction of the high blood glucose level when
compared to the two other different grades of doses of PF.
On the other hand glibenclamide show the decreased level
of blood glucose 65.27.
Effect of PF of plasma insulin
STZ treated group rat significantly decrease in serum
insulin as compared to the normal control groups rat.
Normal control rat received a PF dose (500 mg/kg) shown
slightly improved the plasma insulin level as compared to
the normal control group rat. STZ induced diabetic rat
treated with different doses of PF significantly improved
the plasma insulin level as compared to the diabetic con-
trol group rat (Table 2). On the all three graded doses,
500 mg/kg showed most significant improvement in de-
creasing the insulin level as compared to the diabetic con-
trol group rats.
Effect of PF on glycated haemoglobin (A1c)
Oral administration of different doses of PF was signifi-
cantly decreased the level of glycated haemoglobin (A1c)
in STZ-induced treated diabetic rats (Table 2). The level
of glycated haemoglobin was normal in the wistar rats
fed with normal diet (group I) in conjunction with the
normal control rats received PF with a dose of 500 mg/
kg (group II). STZ induced diabetic rat showed a marked
increase in the level of glycated haemoglobin (A1c) in






















81.8 ± 0.201 79.8 ± 0.245 348.4 ± 2.781a 154.2 ± 1.812b 133.2 ± 0.861b 107.6 ± 1.749b 122 ± 1.844b
2 Fasting Plasma
Insulin (μU/mL)




1.24 ± 0.092 1.24 ± 0.0812 4.86 ± 0.178a 3.96 ± 0.238b 2.82 ± 0.861b 1.52 ± 0.0431b 1.86 ± 0.093b
4 Hexokinase
(μg/mg of tissue)








26.8 ± 1.241 27 ± 1.517 54.8 ± 1.281a 43 ± 1.871b 38.2 ± 1.497b 30 ± 0.707b 31 ± 0.431b
7 Total Cholesterol
(mg/dL)
66.2 ± 1.715 66.8 ± 1.393 141.2 ± 2.634a 129.8 ± 1.53b 101.8 ± 1.934b 76.2 ± 2.01b 84 ± 2.302b
8 Triglycerides
(mg/dL)












15.6 ± 0.295 15.72 ± 0.132 28.96 ± 0.608a 26.2 ± 0.375b 22 ± 0.365b 18.2 ± 0.253b 10.6 ± 0.341b
Values are given as mean ± S.E.M. of six rats in each group. a(P <0.01) compared with the corresponding value for normal control animals (group I); b(P <0.01)
compared with the corresponding value for diabetic control animals (group III); ns-non significant.
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istration of the different doses of PF and glibenclamide
significantly decrease the level of glycated haemoglobin
as compared to the diabetic control.
Effect of PF on hexokinase
Hexokinase level was observed a decline in STZ treated
group rat as compared to the normal control group
(Table 2). Administration of PF dose 500 mg/kg in the
normal rat showed little or no changes in the level of
hexokinase. STZ induced diabetic rat treated with differ-
ent doses of PF showed significant improvement in the
degree of hepatic hexokinase. STZ induced diabetic rat
treated with PF dose 500 mg/kg showed maximum im-
provement in the level of hexokinase as compared to the
other graded dose and glibenclamide treated group rat.
Effect of PF on glucose-6-phosphate
It is the evident from the table that upon oral adminis-
tration of STZ to wistar rats showed the increased level
of glucose-6-phosphatase (Table 2). Oral administration
of the PF dose 500 mg/kg did not show any change inthe level of glucose-6-phosphatase. When STZ induced
diabetic rat treated with different doses of PF, there was a
significant (P < 0.001) decreased the level of glucose-6-
phosphatase in dose dependent manner. Upon administra-
tion of different doses of PF and Glibenclamide, significant
(P < 0.001) decline in the level of glucose-6-phosphatase
has been observed but the dose PF 500 mg/kg was found
to be more effective to decline the high level of glucose-6-
phosphatase.
Effect of PF on fructose-1-6-biphosphatase
The oral administration of PF dose 500 mg/kg has shown
the equal level of fructose-1-6-biphosphatase compared
to the normal control group rats. STZ induced diabetic rats
significantly (P < 0.001) improved the level of fructose-1-
6-biphosphatase as compared to the normal control group
rat (Table 2). Upon oral administration of different doses
of PF leaves extract and glibenclamide significantly (P <
0.001) decline the level of the fructose-1-6-biphosphatase.
The PF dose 500 mg/kg showed the higher decline cap-
ability of fructose-1-6-biphosphatase as compared to the
other dose of the PF and glibenclamide.
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Effect of different doses of PF leaves extract on lipid pro-
file level was evaluated. The level of cholesterol, trigly-
ceride, LDL (low density cholesterol) and VLDL (very
low density cholesterol) were increased and the level of
HDL (high density cholesterol) was decreased in the
STZ induced diabetic rat as compared to the normal
control group rats. The oral administration of PF dose
500 mg/kg to the normal rat did not show any change in
the lipid profile (Table 2). Oral administration of different
doses (100 mg/kg, 250 mg/kg and 500 mg/kg, p.o.) of PF
were showed percentage reduction in cholesterol (14.80%,
22.90%, 32.82%), triglyceride (11.48%, 21.07%, 33.72%),
LDL (26.82%, 44.18%, 65.08%) and VLDL (11.48%, 21.07%,
33.72%), compared to the diabetic control rat group and
the level of HDL (29.93%, 49.64%, 69.34%), was increased
when compared to the diabetic control rat. Oral adminis-
tration of PF dose 500 mg/kg showed the maximum
benefit as compared to the other dose of the PF and glib-
enclamide in reducing the level of cholesterol, triglyceride,
LDL cholesterol and VLDL cholesterol and increasing the
level of HDL cholesterol as compared to the STZ induced
diabetic control rat.
Changes in body weight
STZ treated diabetic rats showed significant loss the
body weight as compared to the normal control group
rat (Table 2). STZ treated diabetic control group rat sig-
nificantly reduced the body weight as compared to the
normal control group rats. STZ induced diabetic rat
treated with different doses of PF (100 mg/kg, 250 mg/kg
and 500 mg/kg) and glibenclamide (10 mg/kg) exhibited
significant (P < 0.001) improvement in the body weight as
compared to the diabetic control group rats.
Effect of PF on antioxidant enzymes
Table 3 represents the activity of the antioxidant enzyme
like SOD, CAT, GPx and MDA in the normal and diabetic













7.8 ± 0.374 7.6 ± 0.245 2.2 ± .374a
2 CAT (U/mg
of protein)
72 ± 1.612 70.6 ± 1.72 38 ± 1.732a
3 GPx (nmole/
mg of protein)
32.8 ± 1.02 32.6 ± 1.208 13.2 ± 0.374a
4 MDA (nmole/
mg of protein)
0.2 ± 0.011 0.21 ± 0.007 0.54 ± 0.013a
Values are given as mean ± S.E.M. of six rats in each group. a(P <0.01) compared wit
compared with the corresponding value for diabetic control animals (group III); ns-nlevel increased in the STZ induced diabetic group rat
(Table 3). Upon administration of PF with dose 500 mg/kg
in the normal control group rat did not indicate any alter-
ation in the level of antioxidant enzymes. Oral administra-
tion of different doses of PF (100 mg/kg, 250 mg/kg and
500 mg/kg) significantly improved the level of SOD, CAT,
GPx and decline the level of MDA as compared to the
normal control group rats. Oral administration of PF
doses (100 mg/kg, 250 mg/kg and 500 mg/kg) brought to
the value to near the normal, similar to the glibenclamide
treated group rats.
Effect of PF on liver
STZ induced diabetic rat liver histopathology has shown
the accumulation of fat droplet and large area of hepato-
cytes as compared to the histopathology of the normal
control group rat liver histopathology. Oral administra-
tion of different doses of PF group rat showed the im-
proved liver histopathology as compared to the diabetic
control group rats (Figure 4). STZ induced diabetic rat
treated with PF dose 100 mg/kg depicted the fat droplet
accumulation in the liver as compared to the normal
control groups rat but less than the diabetic control
group rats. Other graded dose of PF 250 mg/kg showed
the improved effect on the liver histopathology on the
accumulation of the fat droplet as compared to the PF
dose 100 mg/kg and diabetic control group rat. PF dose
500 mg/kg showed the systematic effect and did not
show the any droplet of the fat accumulation on the liver
histopathology as compared to the diabetic control.
Glibenclamide treated group rat shown the liver histo-
pathology similar to the normal control group rats
(Figure 5).
Effect of PF on heart
STZ induced diabetic group rat disturbed the lipid pro-
file and showed direct effect on the heart. Histopath-
ology of heart showed the distorted intercalated discs
and interstitial spaces, in STZ induced diabetic groupr in STZ-induced diabetic rats
TZ diabetes +
F I (100 mg/kg)
STZ diabetes +







4.2 ± 0.374b 5.2 ± 0.374b 7 ± 0.316b 6.6 ± 0.245b
45.8 ± 1.068b 53.8 ± 1.158b 68 ± 1b 65.4 ± 1.077b
19 ± 0.707b 24.6 ± 0.509b 31 ± 0.458b 29.6 ± 0.927b
0.39 ± 0.009b 0.32 ± 0.005b 0.25 ± 0.005b 0.26 ± 0.003b
h the corresponding value for normal control animals (group I); b(P <0.01)
on significant.
Figure 4 Paederia Foetida Linn. leaves extract effect on liver histopathology in normal and STZ induced diabetic rats. (A) Normal
control: Histopathology of normal control rat did not display any sign of the changes (B) Diabetic control: Yellow arrow display the deposition of
the fat micro and macro droplet. (C) PF I (100 mg/kg): STZ induced diabetic rat display the micro droplet deposition on the liver histopathology
(Yellow arrow) (D) PF II (250 mg/kg): PF increasing dose display the few micro droplet deposition of the fats (Yellow arrow) (E) PF III (500 mg/kg):
PF dose 500 mg/kg did not display any change or absorbent. (F) Glibenclamide (10 mg/kg): Glibenclamide treated group rat display the normal
histopathology. The samples were obtained from the same liver anatomical regions. For each group, 6 rats were examined and 80 pictures were
taken. The above picture for each group was chosen randomly from the 50 pictures in this group. Original magnification, 10×.
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http://www.biomedcentral.com/1472-6882/14/76rats (Figure 6). Now, the treatment with different doses
of PF and glibenclamide showed the systematic effect on
the heart histopathology. The distortion of intercalated
discs was decline at dose dependent manner. The dose
PF 500 mg/kg shown the histopathology of the heart al-
most similar to the normal heart. Glibenclamide treated
group rat shown the histopathology similar to the nor-
mal control group rats (Figure 7).Figure 5 Paederia Foetida Linn. leaves extract effect on liver histopath
control: Normal control group did not display any changes (B) Diabetic co
Histopathology display the some pat having the micro droplet of fat depo
the fat deposition (Yellow arrow) (E) PF III (500 mg/kg): PF treated group d
histopathology (F) Glibenclamide (10 mg/kg): Glibenclamide treated group
control group. The samples were obtained from the same liver anatomical
taken. Original magnification, 40×.Effect of PF on kidney
Histopathology of kidney was determined after 28 days
treatment of different doses of PF and glibenclamide in
STZ induced diabetic rats. Normal control group rat kid-
ney histopathology showed the normal size of the bowman
capsule and glomerulus. STZ induced diabetes rats’ kidney
histopathology depicted the inflamed blood vessels, fat de-
position, increase in the thickness of bowman capsules andology in normal and STZ induced diabetic rats. (A) Normal
ntrol: Display the fat deposition (Yellow arrow) (C) PF I (100 mg/kg):
sition (Yellow arrow) (D) PF II (250 mg/kg): PF treated drug displaying
id not display the any changes and fat deposition of the liver
did not display any changes, histopathology similar to the normal
regions. For each group, 6 rats were examined and 50 pictures were
Figure 6 Paederia Foetida Linn. leaves extract effect on heart histopathology in normal and STZ induced diabetic rats. (A) Normal
control: Normal histopathology (B) Diabetic control: Display increased interstitial space and distort the intercalated disc (yellow arrow). (C) PF I
(100 mg/kg): Display less interstitial space and intercalated disc (yellow arrow). (D) PF II (250 mg/kg): PF treated drug display only space in
intercalated disc (yellow arrow). (E) PF III (500 mg/kg): Did not display any changes of the heart histopathology (F) Glibenclamide (10 mg/kg):
Histopathology similar to the normal group. The samples were obtained from the same liver anatomical regions. For each group, 6 rats were
examined and 50 pictures were taken. Original magnification, 10×.
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http://www.biomedcentral.com/1472-6882/14/76change in size of the glomerulus. Oral administration of
different doses of PF reduced the inflammatory blood ves-
sels. The treatment with PF 100 mg/kg dose showed the
reduction of the inflammatory blood vessels and slightly
shorter bowman capsules and glomerulus as compared
to the diabetic control group rat kidney histopathology
(Figure 8). Other PF dose 250 mg/kg kidney histopathology
have shown the disappearance of the inflamed blood ves-
sels and depicted the smaller size of the bowman capsules
and glomerulus. PF dose 500 mg/kg caused completeFigure 7 Paederia Foetida Linn. leaves extract effect on heart histopa
control: Did not display any changes (B) Diabetic control: Histopathology o
distort the intercalated disc (yellow arrow) (C) PF I (100 mg/kg): Histopatho
intercalated disc (yellow arrow) (D) PF II (250 mg/kg): Display only interstiti
disc (Yellow arrow) (F) Glibenclamide (10 mg/kg): Similar display live the no
the same liver anatomical regions. For each group, 6 rats were examined adisappearance of the inflamed blood vessel, but bowman
capsule shown to be slightly bigger as compared to the
normal control group rats. Glibenclamide treated group rat
kidney histopathology did not show the any inflamed blood
vessels and exhibiting the bowman capsules similar to the
normal control group rat histopathology (Figure 9).
Effect of PF on pancreas
Histopathology studies of the experimental rat were mea-
sured after 28 days continuous administration of differentthology in normal and STZ induced diabetic rats. (A) Normal
f diabetic control group rat display increased interstitial space and
logy of tested drug display decreased interstitial space and
al space (yellow arrow) (E) PF III (500 mg/kg): Display some intercalated
rmal control group histopathology. The samples were obtained from
nd 50 pictures were taken. Original magnification, 40×.
Figure 8 Paederia Foetida Linn. leaves extract effect on kidney histopathology in normal and STZ induced diabetic rats. (A) Normal
control: Normal control group rat histopathology shown normal size of glomerulus and bowman capsule (Green arrow) (B) Diabetic control:
Diabetic control group rat histopathology display the inflamed blood vessels (Red arrow), bigger size of bowman capsule, glomerulus and fat
deposition (Yellow arrow) (C) PF I (100 mg/kg): PF tested drug histopathology display the inflammation in blood vessels (brown arrow), bigger
size bowman capsule and fat deposition (yellow arrow) (D) PF II (250 mg/kg): PF treated drug group rat histopathology display fat deposition
(yellow arrow) and inflammatory blood cells (Red arrow). (E) PF III (500 mg/kg): PF treated group display the normal histopathology only increase
the size of bowman capsule (green arrow). (F) Glibenclamide (10 mg/kg): Histopathology of glibenclamide treated group rat display the normal
kidney but bowman capsule bigger in size (Green arrow). The samples were obtained from the same liver anatomical regions. For each group, 6
rats were examined and 50 pictures were taken. Original magnification, 10×.
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http://www.biomedcentral.com/1472-6882/14/76doses of PF and glibenclamide. STZ induced diabetic rat
had shown the reduction of the isles of the Langerhans,
reduced size of β cells and extensive necrosis changes
followed by fibrosis and atrophy. Histopathology studies
of pancreas of STZ induced diabetic rat displayed reduc-
tion of the islets of Langerhans, damaged or reduced sizeFigure 9 Paederia Foetida Linn. leaves extract effect on kidney histop
control: Bowman capsule in average size (B) Diabetic control: Diabetic con
vessels (Red arrow) and fat deposition (Yellow arrow). (C) PF I (100 mg/kg):
arrow) and deposition of fat (Yellow arrow). (D) PF II (250 mg/kg): PF tested
(Yellow arrow) and inflamed cells in blood vessels (Red arrow). (E) PF III (50
changes in the size of bowman capsules. (F) Glibenclamide (10 mg/kg): Gli
histopathology, only bigger size of bowman capsules. The samples were o
6 rats were examined and 80 pictures were taken. Original magnification, 4of β cells and extensive necrosis changes followed by
fibrosis and atrophy (Figure 10). STZ induced diabetic rat
treated with different doses of PF (100 mg/kg, 250 mg/kg,
and 500 mg/kg) and glibenclamide restored the necrotic
and fibrotic changes and raised the number of β cells
(Figure 11).athology in normal and STZ induced diabetic rats. (A) Normal
trol group rat histopathology display inflammatory cells in blood
PF treated group display inflammatory cell in blood vessels (Red
drug group histopathology few parts display the fat deposition
0 mg/kg): PF treated drug display the normal histopathology few
benclamide treated group rat did not display any changes in the
btained from the same liver anatomical regions. For each group,
0×.
Figure 10 Paederia Foetida Linn. leaves extract effect on pancreas histopathology in normal and STZ induced diabetic rats. (A) Normal
control: Normal control group rat histopathology display the normal size of islet of langerhans (Green arrow) (B) Diabetic control: Diabetic control
histopathology display the focal necrosis (yellow arrow) and bigger in the size of islets of langerhans (Black arrow). (C) PF I (100 mg/kg): PF tested
drug display bigger size of islet (Black arrow) and focal necrosis (Yellow arrow). (D) PF II (250 mg/kg): PF tested drug display only focal necrosis
(Yellow arrow) (E) PF III (500 mg/kg): PF tested drug display normal size of islet (Green arrow) (F) Glibenclamide (10 mg/kg): Glibenclamide
treated rat pancreas showing normal islet (Green arrow). For each group 6 rats were examined and 50 pictures were taken. Original
magnification, 10×.
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The present investigation study discusses about the anti-
diabetic, antihyperlipidemic and antioxidant potential ef-
fect of the methanolic leaf extract of Paederia foetida
Linn. in normal and streptozotocin induced diabetic rats.
Phytochemical screening shows that the Paederia foetida
Linn. Leaves extract consists the richest source of the
various bioactive compounds. Acute toxicity studies of
the Paederia foetida Linn. leaf extract reveals the non
toxic nature of the extract at the dose upto 2000 mg/kg,Figure 11 Paederia Foetida Linn. leaves extract effect on pancreas his
control: Normal control group display the normal islet (Red arrow) (B) Diab
enlargement (Blue arrow) and focal necrosis (Yellow arrow) (C) PF I (100 m
arrow) and focal necrosis (Yellow arrow) (D) PF II (250 mg/kg): Other PF tes
(Blue arrow). (E) PF III (500 mg/kg): PF tested drug display normal size of isl
group rat histopathology display normal islet (Red arrow) similar to the nor
pictures were taken. Original magnification, 40×.there was no lethality or any other toxic reactions found
with the selected dose until the conclusion of the study.
In the present study, STZ has been used as a diabeto-
genic agent to induce the diabetes in rodents. Low dose
of STZ has been commonly used for the induction of
type I diabetes (Insulin dependent diabetes mellitus). After
treatment with low dose of STZ survival and regeneration
of pancreatic β-cells is possible in type I diabetes [41].
Streptozotocin (2-deoxy-2-(N-methyl-N-nitrsourea) -1-D-
glucopyranose) is a nitrosourea compound obtained fromtopathology in normal and STZ induced diabetic rats. (A) Normal
etic control: Diabetic control rat histopathology display the islet
g/kg): PF tested drug histopathology display bigger size of islet (Blue
ted drug display focal necrosis (Yellow arrow) and islet enlargement
et (Red arrow) (F) Glibenclamide (10 mg/kg): Glibenclamide treated
mal control group. For each group 6 rats were examined and 50
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the potent alkylating agent that exerts its effect on the
pancreatic β-cells via glucose transporter-GLUT2, causing
induction of methylation of DNA and results in damage
of DNA. Damaged DNA, activate the poly (ADP-Ribose)
polymerase, leading to NAD+ depletion in pancreatic β-
cells [43]. STZ also acts as a nitric oxide donor in pancre-
atic islets, enhances O2
- radical fragmentation in islet cells.
As a result, pancreatic β-cell death occurred by apoptosis
and necrosis ensued, which in turn decreases proinsulin
synthesis [44].
A lot of conventional drugs available in the market to
cure and maintain the blood glucose level in diabetic pa-
tients. But most of the time sulfonylurea, such as gliben-
clamide has been used as a standard antidiabetic drug to
compare the efficacy of a variety of antihyperglycemic
compounds. Glibenclamide exerts their anti-diabetic ac-
tion by stimulating insulin secretion. In our study, we
have compared our plant based drug with the standard
drug, Glibenclamide [45].
In the treatment of diabetes, there is a limited availability
of the oral pharmacological agents. Now the current re-
searches focus on the discovery of the novel oral pharmaco-
logical agents to control of blood glucose, hyperlipidemic
and antioxidant with different mechanism of action. Allo-
pathic medicines are widely available in the market to cure
the diabetes but they are associated with the limitation due
to their specific action and side effect. The best alternate to
cure the diabetes is the alternative system of medicine
which has a very long history. Plant derived antidiabetic
agents are gaining popularity day by day at around the
world for its effectiveness antidiabetic activity and minimal
side effects [46].
In the subject field of the normolglycemic rats, PF
showed the hypoglycaemic effect at dose dependent man-
ner. In the study of the oral glucose tolerance test result
showed the better utilization of the glucose by the ani-
mals. This plausible outcome that the different doses of
the PF extract has the sound capacity to block glucose ab-
sorption. In the OGTT studies [34], it could be concluded
that PF dose 500 mg/kg showed the maximum improve-
ment in the glucose tolerance as compared to the other
dose of PF and glibenclamide.
STZ induced diabetic rat increased the blood glucose
level and decrease the insulin level due to STZ induced
abnormalities in the β cell function [47]. The outcome
of the case indicates that the methanolic leaf extract of
PF restrained the blood sugar level in normoglycaemic,
glucose-hypoglycaemic and STZ induced diabetic rats.
In normoglycemic and STZ induced diabetic rats hypo-
glycaemic action of the PF leaf extract was observed at
dose manner, with prolonged hypoglycaemic effect at
higher dose. The PF dose, 500 mg/kg, is most effective
to diminish the raised blood glucose level. The PF dosehad shown the best result when compared to the syn-
thetic drug glibenclamide (Table 2). The possible mech-
anism of activity of PF leaves extract may be stimulating
the insulin secretion and regeneration of the β-cells of
the pancreas or increasing cellularity of the islet tissue
and regeneration of the granules in the β-cells. Based
upon the result it can be hypothesized that PF declined
the level of the blood glucose and improved the pan-
creas insulin level [45]. This hypothesis has been further
confirmed by the histopathology studies of the pancreas
which showed protection of the pancreas from the toxic
effect of microbial streptozotocin (Figures 10 and 11). The
leaf extract has shown the similar mechanism of action as
glibenclamide, i.e. stimulating the insulin secretion.
In the STZ induced diabetes rats, reduced body weight
was continuously observed. Body weight was continuously
decreasing in the STZ induced diabetic rat due to muscle
destruction or degeneration of structural proteins [48].
Normal rat and STZ induced diabetic rat treated with dif-
ferent doses of the PF leaves extract and glibenclamide, re-
vealed body weight gain as compared to the diabetic
control group rats. The result suggests that the different
doses of the PF and glibenclamide shown the protective
effect in the regulation of the muscle wasting (reversal of
gluconeogenesis). Normal control group rat treated with
PF dose, 500 mg/kg, has shown the better improvement
in the body weight as compared to the diabetic control
and normal control group rats (Table 2).
In normal condition, glycated hemoglobin make 3.4-
5.8% of total hemoglobin and a small portion of blood
glucose, usually 4.5-6%, has been covalently bonded to
the red blood cells in hemoglobin. In diabetic condition
increased level of the glycated hemoglobin due to in-
creased level of blood glucose, which has been added to
the N terminus of hemoglobin and producing the in-
creased level of glycated hemoglobin [49]. In STZ induced
diabetic condition glycated heamoglobin has been in-
creased four times more than the normal level. Our result
lie in agreement with this well known fact that treatment
with PF for 28 days decreased the excess level of the gly-
cated hemoglobin (Table 2), which indicates the improved
echelon of glycemic control.
Some of the researcher claims that the oxidative stress
plays an important role in the microvascular and macro-
vascular complication of diabetes [50]. In diabetes condi-
tion organ damage is the most common problem due to
the defective cell antioxidant response against the oxida-
tive stress generated in the diabetic condition [51]. Oxy-
gen free radical plays an important role in the production
of the oxidative stress. The free radical reacts with all bio-
logical substance, mainly polyunsaturated fatty acids and
this reaction will lead to the cell membrane constituents
lead to the lipid peroxidation [52]. During oxidative stress
increased production of Lipid peroxidation impairs the
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changing the activity of membrane-bound enzyme and re-
ceptors [53]. These findings suggest that antioxidant treat-
ment may be beneficial for diabetic patients. STZ induced
diabetic rat increased the level of the antioxidant marker,
several mechanisms of action are involved like overpro-
duction of the free radical, glucose autooxidation, protein
glycation, formation of advanced glycation products and
polyol pathway [54]. In STZ induced diabetic condition
increased level of the hepatic and renal MDA (as an indi-
cator of the Lipid peroxidation) level and decreasing SOD,
CAT, GPx level indicates the increased free radical gener-
ation. STZ induced diabetic rat treated with different
doses of PF leaf extract decreased the level of MDA and
improved the level of SOD, CAT and GPx. SOD is an im-
portant defense enzymatic antioxidant, the principal activ-
ity of the SOD is scavenge superoxide radical (O2
-) from to
hydrogen peroxide (H2O2) and secondary action dimin-
ishes the toxic effects caused by the free radical reaction.
The other enzymatic antioxidant CAT is a hemoprotein,
which cause reduction of the hydrogen peroxide and
known to be involved in the detoxification of hydrogen
peroxide concentration [55]. The other antioxidant
glutathione peroxidase has been able to reduce lipid
hydroperoxidase and hydrogen peroxide level. STZ in-
duced diabetic rat with higher level of blood glucose
can inactivate the SOD, CAT and GPx by fluctuating
these proteins thus producing induced oxidative stress,
which is turn, cause lipid peroxidation [56]. STZ in-
duced diabetic rat treated with different doses of PF
leaves extract brought back the level of SOD, CAT and
GPx activities near to normal control group rat indicat-
ing the usefulness of PF in attenuating the oxidative
stress in diabetic liver.
In the diabetes condition hypertriglyceridemia and
hypercholestermia are the common factors involved in
the development of the atherosclerosis and coronary heart
disease. This occurs due to lack of the insulin, which acti-
vates the lipase enzyme, hydrolyzed triglyceride (TG) and
releasing the fatty acid and glycerol into the circulating
blood. The level of the triglyceride has been increased in
the STZ induced diabetic rat due to decreased level of in-
sulin, which causes failure to the activate lipoprotein lipase
thereby causing hypertriglyceridemia [57]. STZ induced
diabetes often involves abnormal lipid metabolism which
is a metabolic disorder in diabetes complications [58]. In
diabetes, increased level of total cholesterol, is one of the
major factors for coronary heart disease (hyperlipidaemia)
and its incidence of atherosclerosis. In our studies STZ in-
duced diabetic rats have shown increased level of the total
cholesterol. Treatment with the different doses of PF de-
clines the highest level of total cholesterol and brought
back the normal control level. The exact mode of action is
unknown which involves the decline of total cholesterol.Decline in the cholesterol level achieved by the PF leaf ex-
tract has been shown to have direct effect on lipids or
controlling the blood glucose level. LDL (Low density
lipoprotein) and VLDL (Very low density lipoprotein) start
depositing in the peripheral tissue in the diabetic condi-
tion [45]. STZ induced diabetic rat increased the level of
LDL and VLDL. The treatment has been started with dif-
ferent doses of PF leaf extract produces a decline in the
higher level of LDL and VLDL cholesterol. On the other
hand HDL (High density lipoprotein) cholesterol has been
shown to decrease in the diabetic condition. Treatment
with PF leaf extract for 28 days produces diminished level
of TC, TG, LDL, and VLDL while the level of HDL Chol-
esterol has been significantly reduced [34]. These data
suggest that the PF leaf extract possesses the excellent
ability to ameliorate the lipid profile on the diabetic rats.
The liver plays an important role in the regulation of
glucose metabolizing enzyme. Its regulate glucose-6-
phosphatase, hexokinase and fructose-1-6-biphosphate.
STZ induced diabetic rats have increased the level of
glucose-6-phosphatase, which in turn enhance the pro-
duction of fats from the carbohydrates results in increased
level deposition of fats in the liver and kidney [59]. The
deposition of the fats in the kidney and liver has been sup-
ported by the histopathological study. STZ induced dia-
betic rat treated with different doses of PF significantly
decreased the level of glucose-6-phosphatase. Histopatho-
logical studies also supported the systematic effect of the
PF extract at dose dependent manner. Fructose-1-6-
biphosphateis the other vital enzyme convert glucose into
energy and plays an important role in the glycolysis
[60,61]. STZ induced diabetic rats has been shown to have
increased level of fructose-1-6-biphosphate. Treatment
with PF leaves extract causes sharp decline in the higher
level of fructose-1-6-biphosphate. Other liver enzyme
hexokinase take part in the conversion of glucose into
glucose-6-phosphatase and utilization of the glucose into
the energy [62-65]. In STZ induced diabetic rats the col-
lapse in glucose metabolism, disturb the capacity of the
liver to synthesize glycogen, decline the level of hexoki-
nase and decreased the use of energy. STZ induced dia-
betic rat treated with different doses of the PF leaf extract
improved the level of hexokinase at dose dependent man-
ner (Table 2).
Conclusion
In conclusion, our investigation has clearly indicated
that the leaf extract of Paederia foetida Linn. showed re-
markable antihyperglycemic activity due to its possible
systematic effect involved in the pancreatic and extra
pancreatic mechanism. Furthermore, the antihyperlipi-
demic activity was exerted by lowering the higher level
of lipid profile and decreasing the intercalated disc space
in the heart. The antioxidant activity of extract was due
Kumar et al. BMC Complementary and Alternative Medicine 2014, 14:76 Page 15 of 16
http://www.biomedcentral.com/1472-6882/14/76to inhibition of lipid peroxidation and improved level of
SOD, GPx and CAT. It was corroborateral that the
extract of the Paederia foetida Linn leaves exhibited sig-
nificant antidiabetic, antihyperlipidemic and antioxidant
potential.
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